Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, November 15, 2016

AASLD 2016 Study eyed zinc for slowing progression of chronic liver disease

Study eyed zinc for slowing progression of chronic liver disease

– Oral zinc supplementation was associated with maintenance of liver function and suppression of hepatocellular carcinoma in a retrospective cohort study of 267 patients with chronic liver disease.

Additional analyses revealed stepwise inverse relationships between serum zinc levels and rates of de novo liver failure, hepatocellular carcinoma, and death, Atsushi Hosui, MD, PhD, said at the annual meeting of the American Association for the Study of Liver Diseases. No patients stopped zinc therapy because of adverse events, and there were no serious adverse events, although some patients experienced nausea, which can occur with zinc supplementation, noted Dr. Hosui of Osaka-Rosai Hospital, Japan.

Continue reading....

No comments:

Post a Comment